ProQR Therapeutics II B.V.

AXIOMER

In the heading, Int. Cl. 1 and Int. Cl. 42 should be deleted. In the statement line 5 and lines 10-22, should deleted. In the statement, lines 6-9, should be deleted, except pharmaceutical preparations for the treatment of genetic diseases based on oligonucleotides, rna. In the statement, line 8, before rna for use in should be inserted.;[ Pharmaceutical preparations for the treatment, diagnosis and prevention of genetic diseases and disorders; ] pharmaceutical preparations for the treatment of genetic diseases based on oligonucleotides, [ oligoribonucleotides, aptamers, nucleic acid molecules, dna, ] * for use in * rna [, polynucleotides, ribozymes, mirnas, snornas, mrnas or sirnas ];Color is not claimed as a feature of the mark.;[ Chemical compounds for scientific or research purposes ];[ Laboratory research services relating to pharmaceuticals; medical research; pharmaceutical research and development; laboratory research and analysis in the field of medicines; services of biotechnological, chemical and pharmacological laboratories, including scientific and technological research, in relation to the production of chemicals and biotechnological products for use in the preparation of pharmaceuticals; development of pharmaceutical preparations and medicines; development of technologies for the production of pharmaceutical semi finished and/or finished preparations; academic research, medical and biochemical research and development services; chemistry, laboratory technicians' and engineering services; research and development in the field of biotechnology; research into and development and testing of pharmaceutical and biochemical semi- finished products, in particular for use in medicines, research into and development and testing of medicines; development of test systems for pharmaceutical, medical and sanitizing preparations; services development and identification of and research into new drug targets ];

PROQR

Pharmaceutical preparations for the prevention and treatment of genetic and congenital disorders, metabolic disorders, infectious diseases, cancer and pain relief [ ; veterinary preparations for the prevention and treatment of genetic and congenital disorders, metabolic disorders, infectious diseases, cancer and pain relief; sanitary preparations for medical purposes; dietetic substances, namely, sugar and sugar substitutes adapted for medical use ];[ Chemical compounds for scientific or research purposes ];[ Laboratory research services relating to pharmaceuticals; medical research; pharmaceutical research and development; research and analysis in the field of medicine; biotechnological, chemical and pharmacological laboratory services, namely, scientific and technological research in the field of the production of chemicals and biotechnological products for use in the preparation of pharmaceuticals; development of pharmaceutical preparations and medicines; development of technologies for the production of pharmaceutical semi-finished and finished preparations; academic research services in the medical and biochemical field; laboratory technician services, namely, research and analysis in the field of chemistry; engineering services; research and development in the field of biotechnology; research, development and testing of pharmaceutical and biochemical semi-finished products, in particular for use in medicines; research, development and testing of medicines; development of test systems for pharmaceutical, medical and sanitizing preparations; research and development services relating to new drug targets ];

PROQR

The mark consists of the wording PROQR within a hexagon.;Pharmaceutical preparations for the prevention and treatment of genetic and congenital disorders, metabolic disorders, infectious diseases, cancer and pain relief [ ; veterinary preparations for the prevention and treatment of genetic and congenital disorders, metabolic disorders, infectious diseases, cancer and pain relief; sanitary preparations for medical purposes; dietetic substances, namely, sugar and sugar substitutes adapted for medical use ];Color is not claimed as a feature of the mark.;[ Chemical compounds for scientific or research purposes ];[ Laboratory research services relating to pharmaceuticals; medical research; pharmaceutical research and development; research and analysis in the field of medicine; biotechnological, chemical and pharmacological laboratory services, namely, scientific and technological research in the field of the production of chemicals and biotechnological products for use in the preparation of pharmaceuticals; development of pharmaceutical preparations and medicines; development of technologies for the production of pharmaceutical semi-finished and/or finished preparations; academic research services in the medical and biochemical field; laboratory technician services, namely, research and analysis in the field of chemistry; engineering services; research and development in the field of biotechnology; research, development and testing of pharmaceutical and biochemical semi-finished products, in particular for use in medicines; research, development and testing of medicines; development of test systems for pharmaceutical, medical and sanitizing preparations; research and development services relating to new drug targets ];